CDR-Life is a leader in therapeutic antibody fragments. Based on the companies' proprietary technology platform for making cancer-targeted immunotherapies, it has several game-changing therapy candidates against blood and solid tumor cancers.
Products, services, technology
CDR-Life is developing a diversified portfolio of next generation therapies against cancers and eye disease.
CDR-Life is looking to partner with companies and investors that want to help change the game for cancer patients.